Loading
IARC estimates 41,022 new cancer cases and 25,766 cancer deaths in Sudan in 2024; the commonest new cancers are breast, prostate and Non-Hodgkin lymphoma. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 8,611 | 46.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 3,357 | 26.9 | Prostate cancer |
| Non-Hodgkin lymphoma | 2,728 | 8.2 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 2,501 | 7.6 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Liver and intrahepatic bile ducts | 2,424 | 9.0 | Hepatocellular carcinoma |
| Cervix uteri | 1,711 | 11.5 | Cervical cancer |
| Colorectum | 1,559 | 4.7 | Colorectal cancer |
| Oesophagus | 1,264 | 4.6 | Oesophageal cancer |
| Ovary | 1,198 | 7.3 | Ovarian cancer |
| Nasopharynx | 1,007 | 3.1 |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 3,624 | 20.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 2,289 | 8.6 | Hepatocellular carcinoma |
| Prostate | 2,077 | 16.7 | Prostate cancer |
| Leukaemia | 1,696 | 5.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 1,328 | 4.3 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Cervix uteri | 1,125 | 7.5 | Cervical cancer |
| Oesophagus | 1,123 | 4.1 | Oesophageal cancer |
| Ovary | 809 | 5.2 | Ovarian cancer |
| Colorectum | 804 | 2.6 | Colorectal cancer |
| Trachea, bronchus and lung | 741 | 2.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
No trial record in OnCo lists a site in Sudan. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Sudan.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Sudan is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Sudan is ranked 31 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.